{"created":"2025-02-18T08:54:55.237992+00:00","id":2002793,"links":{},"metadata":{"_buckets":{"deposit":"84484d51-cdc8-4fd7-9857-bcea7124ad82"},"_deposit":{"created_by":41,"id":"2002793","owners":[41],"pid":{"revision_id":0,"type":"depid","value":"2002793"},"status":"published"},"_oai":{"id":"oai:hiroshima.repo.nii.ac.jp:02002793","sets":["1730444908512:1730444911147"]},"author_link":[],"item_1617186331708":{"attribute_name":"Title","attribute_value_mlt":[{"subitem_title":"Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy and Sorafenib for Patients with Advanced Hepatocellular Carcinoma 1) Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status 2) Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis","subitem_title_language":"en"},{"subitem_title":"切除不能進行肝細胞癌に対する肝動注療法とソラフェニブの治療成績の比較 1)脈管侵襲とTACE 不応の観点から、進行肝細胞癌に対する肝動注療法とソラフェニブの治療成績を比較する 2)門脈腫瘍栓を伴う進行肝細胞癌に対する、放射線療法併用肝動注療法とソラフェニブの治療成績を比較する","subitem_title_language":"ja"}]},"item_1617186419668":{"attribute_name":"Creator","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"児玉, 健一郎","creatorNameLang":"ja"},{"creatorName":"Kodama, Kenichiro","creatorNameLang":"en"}],"familyNames":[{"familyName":"児玉","familyNameLang":"ja"},{"familyName":"Kodama","familyNameLang":"en"}],"givenNames":[{"givenName":"健一郎","givenNameLang":"ja"},{"givenName":"Kenichiro","givenNameLang":"en"}]}]},"item_1617186476635":{"attribute_name":"Access Rights","attribute_value_mlt":[{"subitem_access_right":"open access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_abf2"}]},"item_1617186499011":{"attribute_name":"Rights","attribute_value_mlt":[{"subitem_rights":"(c) 2018 S. Karger AG, Basel"},{"subitem_rights":"(c) 2018 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd"}]},"item_1617186626617":{"attribute_name":"Description","attribute_value_mlt":[{"subitem_description":"内容の要旨、審査の要旨","subitem_description_type":"Other"}]},"item_1617186702042":{"attribute_name":"Language","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_1617187087799":{"attribute_name":"Dissertation Number","attribute_value_mlt":[{"subitem_dissertationnumber":"甲第8335号"}]},"item_1617187112279":{"attribute_name":"Degree Name","attribute_value_mlt":[{"subitem_degreename":"博士(医学)","subitem_degreename_language":"ja"},{"subitem_degreename":"Doctor of Philosophy in Medical Science","subitem_degreename_language":"en"}]},"item_1617187136212":{"attribute_name":"Date Granted","attribute_value_mlt":[{"subitem_dategranted":"2020-09-18"}]},"item_1617258105262":{"attribute_name":"Resource Type","attribute_value_mlt":[{"resourcetype":"doctoral thesis","resourceuri":"http://purl.org/coar/resource_type/c_db06"}]},"item_1617353299429":{"attribute_name":"Relation","attribute_value_mlt":[{"subitem_relation_name":[{"subitem_relation_name_text":"Oncology 2018;94:215-222"}]},{"subitem_relation_name":[{"subitem_relation_name_text":"Journal of Gastroenterology and Hepatology 33 (2018) 1780-1786"}]},{"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.1159/000486483","subitem_relation_type_select":"DOI"}},{"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.1111/jgh.14152","subitem_relation_type_select":"DOI"}}]},"item_1617605131499":{"attribute_name":"File","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2023-03-18"}],"displaytype":"simple","filename":"k8335_1.pdf","filesize":[{"value":"109.3 KB"}],"mimetype":"application/pdf","url":{"objectType":"abstract","url":"https://hiroshima.repo.nii.ac.jp/record/2002793/files/k8335_1.pdf"},"version_id":"ab48de83-bc79-492e-95ef-09b377d8b390"},{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2023-03-18"}],"displaytype":"simple","filename":"k8335_2.pdf","filesize":[{"value":"174.6 KB"}],"mimetype":"application/pdf","url":{"objectType":"abstract","url":"https://hiroshima.repo.nii.ac.jp/record/2002793/files/k8335_2.pdf"},"version_id":"f549c9c4-e7a3-4417-801a-c86cfae3b8a2"}]},"item_1617944105607":{"attribute_name":"Degree Grantor","attribute_value_mlt":[{"subitem_degreegrantor":[{"subitem_degreegrantor_language":"ja","subitem_degreegrantor_name":"広島大学"}],"subitem_degreegrantor_identifier":[{"subitem_degreegrantor_identifier_name":"15401","subitem_degreegrantor_identifier_scheme":"kakenhi"}]},{"subitem_degreegrantor":[{"subitem_degreegrantor_language":"en","subitem_degreegrantor_name":"Hiroshima University"}]}]},"item_1732771732025":{"attribute_name":"旧ID","attribute_value":"50341"},"item_1732772494514":{"attribute_name":"備考","attribute_value":"全文は、出版社の規定によりリポジトリでの公開が認められておりませんので、関連情報URLをご覧下さい。"},"item_title":"Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy and Sorafenib for Patients with Advanced Hepatocellular Carcinoma 1) Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status 2) Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis","item_type_id":"40003","owner":"41","path":["1730444911147"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2023-03-18"},"publish_date":"2023-03-18","publish_status":"0","recid":"2002793","relation_version_is_last":true,"title":["Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy and Sorafenib for Patients with Advanced Hepatocellular Carcinoma 1) Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status 2) Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis"],"weko_creator_id":"41","weko_shared_id":-1},"updated":"2025-02-19T10:31:53.905342+00:00"}